Imaging assessment of natalizumab in multiple sclerosis: preliminary results on MRI/MRS and PET data

被引：0
|
作者：
Detour, J. [1 ]
Namer, I-J. [1 ]
Kremer, S. [1 ]
De Seze, J. [1 ]
机构：
[1] Univ Hosp, Strasbourg, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P845
引用
收藏
页码：S376 / S377
页数：2
相关论文
共 50 条
  • [41] Systematic assessment of JC virus in multiple sclerosis patients treated with natalizumab
    Slesari, I.
    Heinzlef, O.
    Poveda, J. -D.
    JOURNAL OF NEUROLOGY, 2010, 257 : S220 - S220
  • [42] Imaging of microglial activation with PET and atrophy with MRI in multiple sclerosis: Interrelationship and clinical correlates.
    Versijpt, J
    Debruyne, J
    Van Laere, K
    De Vos, F
    Keppens, J
    Strijckmans, K
    Achten, E
    Slegers, G
    De Reuck, J
    Korf, J
    Dierckx, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 20P - 21P
  • [43] Systemic assessment of JC virus in multiple sclerosis patients treated with natalizumab
    Slesari, I.
    Manzouni, T.
    Brugeilles, H.
    Romatet, S.
    Chamouard, J.
    Poveda, J. D.
    Heinzlef, O.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S120 - S120
  • [44] A portable device for assessment of psychomotor function: preliminary data in multiple sclerosis patients
    Leocani, L
    Montagna, M
    Annovazzi, R
    Baldissera, F
    Lanzillo, R
    Tomassini, V
    Millevolte, M
    Balugani, R
    Ortu, E
    Gasperini, C
    Ghezzi, V
    Comi, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S120 - S120
  • [45] Advanced Imaging Techniques in the Diagnosis of Nonlesional Epilepsy: MRI, MRS, PET, and SPECT
    Pardoe, Heath
    Kuzniecky, Ruben
    EPILEPSY CURRENTS, 2014, 14 (03) : 121 - 124
  • [46] MRI Assessment of Iron Deposition in Multiple Sclerosis
    Ropele, Stefan
    de Graaf, Wolter
    Khalil, Michael
    Wattjes, Mike P.
    Langkammer, Christian
    Rocca, Maria A.
    Rovira, Alex
    Palace, Jacqueline
    Barkhof, Frederik
    Filippi, Massimo
    Fazekas, Franz
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2011, 34 (01) : 13 - 21
  • [47] Plasma exchange accelerates the decline of serum natalizumab concentration in patients with multiple sclerosis: Results of the natalizumab PLEX study
    Khatri, Bhupendra
    Fox, Robert
    Koo, Anna P.
    Lynn, Frances
    Duda, Petra
    Jurgensen, Stephanie
    Panzara, Michael
    Giovannoni, Gavin
    NEUROLOGY, 2008, 70 (11) : A227 - A228
  • [48] 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a:: results of a preliminary study
    Sarchielli, P
    Presciutti, O
    Tarducci, R
    Gobbi, G
    Alberti, A
    Pelliccioli, GP
    Orlacchio, A
    Gallai, V
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (02): : 204 - 212
  • [49] Natalizumab in paediatric multiple sclerosis: long-term results of 55 cases
    Ghezzi, A.
    Pozzilli, C.
    Moiola, L.
    Morra, V. Brescia
    Grimaldi, L. M. E.
    Lus, G.
    Rinaldi, F.
    Rocca, M. A.
    Trojano, M.
    Bianchi, A.
    Filippi, M.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 301 - 302
  • [50] Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
    Putzki, Norman
    Yaldizli, Ozgur
    Buhler, Robert
    Schwegler, Guido
    Curtius, Daniela
    Tettenborn, Barbara
    EUROPEAN NEUROLOGY, 2010, 63 (02) : 101 - 106
12345